West Nile fever - Symptoms, Causes, Treatment & Prevention

```html

Overview

West Nile fever (WNF) is an infection caused by the West Nile virus (WNV), a mosquito‑borne flavivirus. Most people who become infected develop no symptoms or only a mild, flu‑like illness; about 1 in 5 develop the classic febrile illness known as West Nile fever, and a small fraction (<1 %) develop severe neuroinvasive disease such as meningitis or encephalitis.

The virus circulates worldwide, primarily in Africa, Europe, the Middle East, and the Americas. In the United States the first confirmed human case was reported in 1999 in New York, and since then the disease has become endemic in many states, especially those with warm summers and abundant mosquito habitats.

• Incidence: The CDC reports an average of ~7,000 WNV cases in the U.S. each year (2010‑2022), with approximately 2,000–3,000 neuroinvasive cases annually.
• Age & gender: Adults over 50 are at highest risk for severe disease; males are slightly more likely to be infected.
• Geography: Highest activity is observed in the central and western United States, the Mediterranean region, and parts of sub‑Saharan Africa.

Symptoms

Symptoms typically appear 2–14 days after a mosquito bite (the incubation period).

Typical West Nile fever (non‑neuroinvasive)

• Fever – often 101‑104 °F (38.5‑40 °C).
• Headache – may be severe and feel “pressure‑like.”
• Muscle aches (myalgia) – especially in the arms, legs, and back.
• Joint pain (arthralgia).
• Fatigue – can last weeks.
• Gastrointestinal upset – nausea, vomiting, abdominal pain, sometimes diarrhea.
• Skin rash – maculopapular rash on trunk or limbs (seen in ~10 % of cases).

Neuroinvasive West Nile disease (less common, but serious)

• Meningitis – stiff neck, photophobia, severe headache.
• Encephalitis – confusion, memory loss, seizures, weakness, paralysis.
• Acute flaccid paralysis – sudden weakness in one limb, mimicking polio.
• Movement disorders – tremor or unsteady gait.

Symptoms of neuroinvasive disease usually develop within a few days after the initial fever and may progress rapidly.

Causes and Risk Factors

Cause

West Nile virus is transmitted to humans primarily through the bite of an infected Culex mosquito. The virus maintains a natural cycle among birds (especially passerine species) and mosquitoes; humans and other mammals are “dead‑end” hosts, meaning they do not transmit the virus further.

Risk Factors

• Geographic exposure – living in or traveling to areas with known WNV activity.
• Outdoor activity – especially dusk‑to‑night, when Culex mosquitoes feed.
• Age ≥50 years – immune senescence increases susceptibility to severe disease.
• Immunocompromised state – HIV/AIDS, organ transplant, chemotherapy.
• Chronic conditions – diabetes, hypertension, renal disease, or cardiovascular disease.
• Male sex – modestly higher infection rates observed.

Diagnosis

Diagnosis is based on clinical presentation, exposure history, and laboratory testing.

Laboratory Tests

• Serology (IgM/IgG ELISA) – detection of WNV‑specific IgM antibodies in serum or cerebrospinal fluid (CSF) is the most common method. IgM appears within 3‑8 days of symptom onset and can persist for months.
• Polymerase chain reaction (PCR) – detects viral RNA in blood, CSF, or urine. PCR is most useful during the first week of illness when viremia is highest.
• Plaque reduction neutralization test (PRNT) – confirmatory test used in research or when cross‑reactivity with other flaviviruses is suspected.
• Complete blood count (CBC) – may show mild leukopenia or thrombocytopenia.
• CSF analysis (for neuroinvasive disease) – typically shows elevated protein, normal or slightly low glucose, and a lymphocytic pleocytosis.

Imaging

If encephalitis is suspected, magnetic resonance imaging (MRI) can reveal hyperintensities in the basal ganglia, thalamus, or brainstem, but imaging is not required for diagnosis.

Treatment Options

There is no specific antiviral therapy approved for West Nile virus. Management focuses on supportive care.

Supportive Care

• Hydration – oral or intravenous fluids to prevent dehydration.
• Pain and fever control – acetaminophen is preferred; avoid aspirin or NSAIDs in children until bacterial infection is excluded to reduce bleeding risk.
• Rest – adequate sleep aids immune recovery.
• Hospitalization – indicated for neuroinvasive disease, severe dehydration, or patients with high‑risk comorbidities.
• Respiratory support – oxygen or mechanical ventilation for severe encephalitis.

Investigational Therapies

Several agents (e.g., interferon‑α, ribavirin, monoclonal antibodies) have shown in‑vitro activity, but clinical trials have not demonstrated clear benefit, and they are not routinely recommended (NIH, 2023).

Rehabilitation

Patients recovering from neuroinvasive disease may need physical, occupational, or speech therapy to address weakness, coordination problems, or cognitive deficits.

Living with West Nile Fever

Most people recover fully within weeks, but fatigue and mild neurologic symptoms can linger for months. Here are practical tips for daily management:

• Hydrate – aim for 2–3 L of water daily unless fluid restriction is advised.
• Monitor temperature – keep a log; seek care if fever persists >5 days.
• Rest and pacing – avoid strenuous activity until fatigue resolves.
• Nutrition – eat a balanced diet rich in fruits, vegetables, and lean protein to support immune function.
• Medication safety – use acetaminophen per label; avoid combining with other acetaminophen‑containing products.
• Follow‑up – schedule a post‑illness visit to ensure recovery and address any lingering neurologic deficits.
• Vaccination status – while no human vaccine exists for WNV, keep routine vaccinations up‑to‑date (e.g., influenza, COVID‑19) to reduce overall illness burden.

Prevention

Because no vaccine is available for humans, prevention relies on reducing mosquito exposure.

• Use EPA‑registered insect repellent containing DEET (20‑30 %), picaridin, IR3535, or oil of lemon eucalyptus. Reapply every 3‑5 hours.
• Wear protective clothing – long sleeves, long pants, and socks when outdoors during peak mosquito hours (dusk to dawn).
• Eliminate standing water – empty birdbaths, gutters, flower pots, and any containers that collect rain.
• Install or repair screens on windows and doors.
• Use indoor mosquito control – plug‑in insecticide vaporizers or UV traps.
• Community‑level measures – support local vector‑control programs that conduct larviciding and adulticiding when WNV activity rises.
• Travel precautions – research WNV activity in destination areas and follow the same personal protection steps.

Complications

While most infections are self‑limited, complications can be serious, especially in high‑risk groups.

• Neuroinvasive disease – meningitis, encephalitis, or acute flaccid paralysis can cause permanent neurologic deficits.
• Secondary infections – prolonged hospitalization increases risk of bacterial pneumonia or urinary tract infection.
• Chronic fatigue syndrome – a subset of patients report lasting fatigue for >6 months.
• Renal or cardiac involvement – rare cases of myocarditis or acute kidney injury have been reported.

Long‑term sequelae occur in up to 30 % of patients with neuroinvasive disease, ranging from mild memory problems to severe motor impairment (Cleveland Clinic, 2022).

When to Seek Emergency Care

---

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, peer‑reviewed journals (J Infect Dis 2021; 224: 181‑190; Lancet Infect Dis 2023; 23: 456‑466).

```